Definitive Contract HHSN271201400065C

The Defense Logistics Agency Troop Support Medical (DLA) awarded a $302,936.93 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The contract is for the provision of 4556038807 Naloxone Hydrochloride to the DLA and will be performed from December 21, 2021 through December 22, 2021 at the prime contractor's place of performance in Park Ridge, Illinois. Naloxone Hydrochloride is used to treat opioid overdoses. No applicable subcontractors were...

This is a $113,800,349 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Indivior Inc., a for-profit pharmaceutical manufacturer based in Richmond, Virginia. The contract is for the provision of an intranasal nalmefene drug-device combination product to treat opioid overdoses. The original solicitation was a special notice published by ASPR seeking input on...

The National Institute on Drug Abuse awarded a delivery order valued at $1.04 million to The Emmes Company, LLC for Task Order 11 under the Clinical Trials Network Clinical Coordinating Center contract. This delivery order supports a clinical research study titled "Standard Versus High Dose ED-Initiated Buprenorphine Induction," with a performance period running from August 28, 2023 through August 27, 2024. The contract utilizes a cost-plus-fixed-fee pricing structure and does not...

The Defense Logistics Agency Troop Support Medical awarded a $459,999 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4561610751 Naloxone Hydrochloride to be delivered between July 10-11, 2023. Naloxone Hydrochloride is an opioid antagonist used for reversing opioid overdoses. This delivery order was awarded under the Medical-Surgical Prime Vendor contract, a multiple award indefinite delivery/indefinite quantity contract managed by...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at one hundred fifty-three thousand three hundred thirty-three dollars to DMS Pharmaceutical Group Incorporated, located in Park Ridge, Illinois. The order is for naloxone hydrochloride to be delivered between July 11-12, 2023. As a Schedule 65 I federal supply class medical item, naloxone hydrochloride is an opioid antagonist used to treat opioid overdoses. This delivery order was issued...

The Department of Justice Drug Enforcement Administration (DEA) awarded a $136,383.00 firm fixed price purchase order to The Mclean Hospital Corporation, a non-profit research hospital affiliated with Harvard Medical School, to conduct a study on the drug discrimination and locomotor activity of 15 designer benzodiazepine substances. This study aims to gather pharmacological, medical, and epidemiological data to support the DEA's efforts to place these substances under regulatory control under...

The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Orexo US Inc. for clinical development of OX390 (atipamezole) as an α2 agonist reversal agent to counteract sedative effects of xylazine, medetomidine, and other α2 agonists on September 24, 2025, under a cost-sharing pricing arrangement with a ceiling value of $50.9 million. The contract arises from a BARDA solicitation for medical countermeasures against chemical, biological, radiological,...

The Defense Logistics Agency Troop Support Medical awarded a $1,582.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the order, DMS will provide 4561949141 Naloxone Hydrochloride Nasal Spray 2-Pak kits to the agency. Naloxone is used to rapidly reverse opioid overdoses. The order has a period of performance from August 25 to August 28, 2023. No subcontractors or set aside designations were identified. This order was placed under an existing DLA...

This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...

This federal contract award to Emergent Devices, Inc. is for the provision of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract is a delivery order placed under Emergent Devices' Federal Supply Schedule 65 IB contract with the Department of Veterans Affairs Veterans Health Administration. The contract has a firm-fixed price of $1,356,840.00 and a completion date of October 2, 2017. No set-aside designation was used. This contract...